Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 39 min 16 sec ago

OnCore Biopharma Closes Series R Financing

Fri, 09/05/2014 - 12:39
Funds to Expand OnCore's Portfolio of Oral Therapeutics for the Treatment of Chronic HBV OnCore to Advance HBV Compounds Into Phase 1 Clinical Development During 2015 Former Pharmasset Team Leveraging Expertise in Hepatitis R&D DOYLESTOWN, Pa., S...
Biopharmaceuticals, Venture Capital
OnCore Biopharma, hepatitis B

Aurora Spine Appoints Vice President of Sales

Thu, 09/04/2014 - 14:00
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the appointment of Mike Wheelock as Vice President of Sales. Mr. Wheelock will be responsible for Aurora's United States sales efforts...
Devices, Orthopaedic, Neurosurgery, Personnel
Aurora Spine

Geneia Inks Multi-Year Partnership with Covidien to Enter $21 Billion Remote Patient Monitoring Market

Thu, 09/04/2014 - 13:55
ZephyrLIFE™ Technology from Covidien Powers Geneia's Remote Patient Monitoring Solution for the Home HARRISBURG, Pa. and CONCORD, N.H., Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Geneia® today announced a multi-year, strategic partn...
Devices, Monitoring
Geneia, Covidien, ZephyrLIFE

Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development

Thu, 09/04/2014 - 13:51
CORAL GABLES, Fla., Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Catalyst Pharmaceutical Partners, Inc. (CPRX), (Catalyst Pharmaceuticals), a biopharmaceutical company focused on developing and commercializing innovative therapies for people ...
Biopharmaceuticals, Personnel
Catalyst Pharmaceutical Partners

Chimerix Appoints W. Garrett Nichols, MD, MS as Chief Medical Officer

Thu, 09/04/2014 - 13:48
Essy Mozaffari, PharmD, MPH, MBA appointed Vice President, Market Access and Reimbursement Odin Naderer, PharmD, appointed Vice President, Clinical Pharmacology and Translational Medicine DURHAM, N.C., Sept. 4, 2014 -- (Healthcare Sales & Marketing N...
Biopharmaceuticals, Personnel

EndoCross Receives CE Mark Approval for the ENABLER-C Coronary Catheter System for the Crossing of Coronary Chronic Total Occlusions

Thu, 09/04/2014 - 13:45
YOKNEAM, Israel--(Healthcare Sales & Marketing Network)--EndoCross, Ltd., received CE Mark approval for the ENABLER-C Coronary Catheter System. The ENABLER-C features a unique controlled guidewire advancement technology currently available in the CE Marked...
Devices, INterventional Cardiology, Regulatory
EndoCross, ENABLER-C, Coronary Catheter, chronic total occlusions

Yale-New Haven Hospital Upgrades to Masimo SET(R) Pulse Oximetry for Improved Patient Outcomes

Thu, 09/04/2014 - 13:40
NEW HAVEN, CT and IRVINE, CA--(Healthcare Sales & Marketing Network) - Masimo (NASDAQ: MASI) today announced that Yale-New Haven Hospital -- a nonprofit, 1,541-bed tertiary medical center ranked among the best in the U.S. -- has upgraded system-wide to Ma...
Devices, Monitoring
Masimo, Masimo SET, pulse oximetry

Esaote Receives FDA Clearance for Its Compact MyLab Six Ultrasound System

Thu, 09/04/2014 - 13:35
Configurable applications and compact design combine in new affordable shared service ultrasound INDIANAPOLIS--(Healthcare Sales & Marketing Network)--Esaote North America announced that its new MyLab Six ultrasound system has received 510(k) clearance ...
Devices, FDA
Esaote North America, MyLab Six, ultrasound

Stereotaxis Receives FDA Clearance of Vdrive(TM) With V-Loop(TM) System

Thu, 09/04/2014 - 13:28
ST. LOUIS, Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Stereotaxis, Inc. (STXS) announced today that it has received 510(k) clearance by the Food and Drug Administration (FDA) to market its Vdrive(TM) Robotic Navigation System with V-Loop(TM...
Devices, FDA
Stereotaxis, Vdrive, Robotic Navigation System

Johnson and Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid

Thu, 09/04/2014 - 13:22
NEW BRUNSWICK, N.J., Sept. 4, 2014 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson (JNJ) today announced it will fast-track the development of a promising new combination vaccine regimen against Ebola and broadly collaborate with its partne...
Johnson & Johnson, Crucell, Janssen, Ebola, Filoviridae

BIND Therapeutics Appoints Two New Board Members

Wed, 09/03/2014 - 15:44
Industry leaders, Eric K. Rowinsky, M.D. and Amy W. Schulman, join BIND’s Board of Directors CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--BIND Therapeutics, Inc. (BIND), a clinical-stage nanomedicine platform company developing targeted and...
Biopharmaceuticals, Oncology, Personnel
BIND Therapeutics, Accurins, Medicinal Nanoengineering

Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board

Wed, 09/03/2014 - 15:42
EWING, N.J., Sept. 3, 2014 -- (Healthcare Sales & Marketing Network) -- Celator Pharmaceuticals, Inc. (CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the appointment of Michael R. Dougherty as C...
Biopharmaceuticals, Oncology, Personnel
Celator Pharmaceuticals

MRI Interventions Welcomes Pascal E.R. Girin to Board of Directors

Wed, 09/03/2014 - 15:40
Newest Director Brings Additional Medical Device Management Experience, Executive Perspective to Board IRVINE, Calif., Sept. 3, 2014 -- (Healthcare Sales & Marketing Network) -- MRI Interventions, Inc. (MRIC) today announced that industry veteran Pascal...
Devices, Radiology, Surgery, Personnel
MRI Interventions, ClearPoint, intraoperative MRI

GE Healthcare Announces FDA Approval of SenoClaire, New Breast Imaging with 3D Tomosynthesis Solution

Wed, 09/03/2014 - 15:19
WAUWATOSA, Wis.--(Healthcare Sales & Marketing Network)--GE Healthcare (GE) today announced the FDA approval of SenoClaire*, GE’s new breast tomosynthesis solution designed with a three-dimensional imaging technology. In collaboration with Massachusetts Ge...
Devices, Radiology, Oncology, FDA
GE Healthcare, SenoClaire, breast tomosynthesis, imaging

ProNAi Therapeutics, Inc. Names New President and Chief Executive Officer

Wed, 09/03/2014 - 15:16
PLYMOUTH, Mich.--(Healthcare Sales & Marketing Network)--ProNAi Therapeutics, Inc., a developer of novel nucleic acid therapeutics, announces the appointment Nick Glover, Ph.D. as President and Chief Executive Officer. The company’s previous CEO, Mina Sooc...
Biopharmaceuticals, Personnel
ProNAi Therapeutics

SinuSys Corp. Names Robert Hoxie as Chief Commercial Officer

Wed, 09/03/2014 - 15:14
PALO ALTO, Calif.--(Healthcare Sales & Marketing Network)--SinuSys Corp., an innovative sinus health company, today announced that Robert Hoxie has joined the company as chief commercial officer, effective September 1. Mr. Hoxie will provide strategic sale...
Devices, Personnel
SinuSys, Vent-Os, Sinus Dilation System

Intensity Therapeutics, Inc. Appoints Ian B. Walters M.D., MBA as Vice President and Chief Medical Officer

Wed, 09/03/2014 - 15:12
WESTPORT, Conn.--(Healthcare Sales & Marketing Network)--Intensity Therapeutics, Inc., a privately-held specialty pharmaceutical company developing novel products to treat solid tumor cancers, announced today that Ian B. Walters M.D., MBA, has been appoint...
Biopharmaceuticals, Oncology, Personnel
Intensity Therapeutics, in situ chemovaccination

Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer

Wed, 09/03/2014 - 15:10
Industry Veteran Brings More than 35 Years of Expertise in CNS Drug Discovery and Development CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Voyager Therapeutics, a gene therapy company developing life-changing treatments for fatal and debili...
Biopharmaceuticals, Neurology, Personnel
Voyager Therapeutics

Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.

Wed, 09/03/2014 - 15:08
WOODCLIFF LAKE, N.J., Sept. 3, 2014 -- (Healthcare Sales & Marketing Network) -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced it has entered into an agreement with Concordia Pharmaceuticals Inc. ("Concordia"...
Biopharmaceuticals, Acquisitions
Eisai, Concordia Pharmaceuticals, Zonegran, zonisamide

Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer

Wed, 09/03/2014 - 14:55
New US Subsidiary to be located in the Philadelphia Area VIENNA, September 3, 2014 -- (Healthcare Sales & Marketing Network) --Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the tre...
Biopharmaceuticals, Personnel
Nabriva Therapeutics, antibiotic, pleuromutilins

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong